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Role of the Intracellular pH in the Metabolic Switch
between Oxidative Phosphorylation and Aerobic
Glycolysis - Relevance to Cancer
Abstract
Cellular energy in the form of ATP can be produced
through oxidative phosphorylation and through
glycolysis. Since oxidative phosphorylation requires
oxygen and generates ATP more efficiently than
glycolysis, it has been assumed for many years that
the presence or absence of oxygen determines that
cel ls  generate energy through ox idat ive
phosphorylation or through glycolysis. Although cells
must activate glycolysis in the absence of oxygen to
produce ATP, it is now accepted that they can activate
both glycolysis and oxidative phosphorylation in the
presence of oxygen. In fact, normal proliferating cells
and tumor cells are known to have a high glycolytic
activity in the presence of adequate oxygen levels, a
phenomenon known as aerobic glycolysis or the
Warburg effect. Recent observations have
demonstrated that the activation of aerobic glycolysis
plays a major role in carcinogenesis and tumor growth.
Understanding the mechanisms involved in the
metabolic switch between oxidative phosphorylation
and aerobic glycolysis may therefore be important for
the development of potential preventive and
therapeutic interventions. In this article, we discuss the
role of the intracellular pH in the metabolic switch
between oxidative phosphorylation and aerobic
glycolysis. We propose that, in the presence of
adequate oxygen levels, the intracellular pH may play
a key role in determining the way cells obtain energy,
an alkaline pH driving aerobic glycolysis and an acidic
pH driving oxidative phosphorylation.
Introduction
C e l l s  r e q u i r e  e n e r g y  i n  t h e  f o r m  o f
adenosine-5-triphosphate (ATP) to carry out numerous
cellular processes. Most ATP molecules are produced
in the mitochondria through oxidative phosphorylation
(oxphos), an oxygen-dependent process that couples
the oxidation of NADH and FADH2 with the
phosphorylation of ADP to form ATP. Oxphos requires
oxygen because the electrons resulting from the
oxidation of NADH and FADH2 need to be ultimately
accepted by oxygen. Cells can also produce ATP
through glycolysis, which takes place in the cytosol
and does not require oxygen. In the glycolytic process,
one molecule of glucose is transformed into two
molecules of pyruvate resulting in the production of
ATP. This transformation consumes NAD+, which can
be regenerated by the conversion of pyruvate to
lactate. Because oxphos is over ten times more
efficient than glycolysis in generating ATP, it is
comprehensible that cells generate ATP through
oxphos when the oxygen levels are adequate. This
was first noted by Louis Pasteur in the late 19th century,
who observed that the generation of ATP shifted from
oxphos to glycolysis when the  oxygen levels
decreased (Pasteur effect) (1-3).
Several decades later the biochemist Otto Warburg
first observed that cancer cells had increased
glycolytic activity despite the presence of an adequate
oxygen supply (4). This phenomenon, called aerobic
glycolysis or Warburg effect, has repeatedly been
observed and is currently used worldwide as a
diagnostic tool to detect malignant tumors
(Fluorodeoxyglucose - Positron Emission Tomography:
FdG-PET) (5). It is important to mention that the
metabolic switch from oxphos to aerobic glycolysis is
not a unique feature of tumor cells, because it has also
been observed in non-transformed proliferating cells
(6-8). It is also important to note that, although normal
proliferating cells and tumor cells activate aerobic
glycolysis, these cells also rely on oxphos for their
ATP production (4,9).
Although it is now accepted that the Warburg effect
plays an important role in carcinogenesis and tumor
growth, it is not clear why and how this phenomenon
occurs. We have proposed previously that normal
proliferating cells and tumor cells need to activate
glycolysis despite the presence of oxygen in order to
proliferate (10-12). Cell proliferation requires the
synthesis of new macromolecules (e.g., nucleic acids,
lipids, proteins) and glycolysis provides building blocks
(e.g. glucose 6-phosphate, dihydroxyacetone
phosphate, 3-phosphoglycerate, phosphoenolpyruvate,
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pyruvate) that participate in the synthesis of these
macromolecules. This means that cell proliferation
would be compromised if glycolysis were always
inhibited in the presence of oxygen, and can explain
why tumor cells and normal proliferating cells activate
glycolysis under aerobic conditions (10-12). As to how
cells switch from oxphos to aerobic glycolysis, several
mechanisms have been proposed (9,11). Less focus
has been placed on how cells come back from aerobic
glycolysis to oxphos, probably because it has been
considered for some time that the Warburg effect was
caused by irreversible damages to oxphos (4,13).
Because aerobic glycolysis plays a key role in cancer
development, understanding how cells switch from
aerobic glycolysis to oxphos could be important for the
development of potential preventive and therapeutic
interventions. In this article, we discuss evidence that
the cytosolic concentration of protons (intracellular pH)
may play a key role in the metabolic switch between
oxidative phosphorylation and aerobic glycolysis, an
alkaline pH driving aerobic glycolysis and an acidic pH
driving oxidative phosphorylation.
An alkaline intracellular pH may drive the
metabolic switch from oxidative phosphorylation
to aerobic glycolysis
In the process of oxphos, high-energy electrons from
NADH and FADH 2  a re  passed a long the
electron-transport chain, located in the inner
mitochondrial membrane, to oxygen (illustration 1).
This electron transport drives protons (H+) pumping
from the mitochondrial matrix to the intermembrane
space, which generates an electrochemical H+
gradient across the inner mitochondrial membrane.
This electrochemical H+ gradient (or proton motive
force) drives H+ entry into the mitochondrial matrix
through ATP synthase, a transmembrane protein
complex that uses the energy of the H+ flow to
synthesize ATP from ADP and inorganic phosphate (Pi
). Therefore, as shown in illustration 1, ATP generation
through oxphos ult imately depends on an
electrochemical H+ gradient across the inner
mitochondrial membrane. This H+ gradient also drives
pyruvate and Pi transport into the mitochondrial matrix
(2).
The outer mitochondrial membrane contains transport
proteins called voltage dependent anion channels
(VDAC), or mitochondrial porins, which form large
channels through the lipid bilayer (2,14-16). When
VDACs are open, the intermembrane space and the
cytosol are supposed to be chemically equivalent with
respect to the small molecules they contain, including
H+ (2). This means that a decrease in the cytosolic
concentration of H+ (intracellular alkalinization) would
decrease the concentration of H+ in the mitochondrial
intermembrane space. This would reduce the
electrochemical H+ gradient across the inner
mitochondrial membrane and would repress oxphos
even in the presence of adequate oxygen levels
(illustration 1) (2,17).
It is important to note that, when VDACs are closed,
the concentration of protons in the mitochondrial
intermembrane space may be rather different than that
in the cytosol. Indeed, pH differences across the outer
mitochondrial membrane have been measured in
tumorigenic ECV304 cells (18,19). Evidence indicates
that hexokinase can repress oxphos in tumor cells by
binding to VDAC and inducing its closure (9,14-16,20).
Interestingly, hexokinase binding to mitochondria is
strongly dependent on the intracellular pH; an alkaline
pH would increase hexokinase binding and activity
(21), and would lead to VDAC closure and repression
of mitochondrial activity (14). This supports the idea
that intracellular alkalinization can repress oxphos.
In addition to repressing oxphos, a decrease in the
cytosolic concentration of H+ can stimulate glycolysis.
The key glycolytic enzyme phosphofructokinase (PFK)
is well-known to be repressed by ATP (2). Intracellular
alkalinization-induced oxphos repression would
decrease cellular ATP levels; this would release PFK
inhibition by ATP and would increase glycolysis to
compensate such ATP deficit. In addition, evidence
indicates that intracellular alkalinization activates
glycolysis by directly increasing the activity of PFK.
The enzyme PFK is extremely sensitive to small
changes in pH in the physiological range, a high pH
increasing its activity (22,23). In fact, an increase in pH
of 0.1-0.3 units can change the activity of PFK from an
inactive form to a saturated state (22). 
Although the activation of the enzyme PFK is
fundamental for the activation of glycolysis, cells need
to increase the expression of glucose transporters (e.g.
GLUTs) and glycolytic enzymes (e.g. hexokinase, PFK,
pyruvate kinase) to keep sustained glycolytic rates.
 Hypoxia-inducible factor 1 (HIF-1) plays a key role in
the transcription of genes that code for glucose
transporters and glycolytic enzymes (24-27).
Interestingly, it has been demonstrated that the
glucose metabolite pyruvate increases HIF-1 activity
under aerobic conditions by preventing HIF-1
degradation (28,29). As represented in illustration 2,
the activation of glycolysis would increase the cellular
levels  of  pyruvate.  The reduct ion in  the
electrochemical H+ gradient across the inner
mitochondrial membrane induced by intracellular
alkalinization would decrease pyruvate entry into the
mithochondrial matrix, which would increase the
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cytosolic concentrations of pyruvate further (illustration
1). The increased pyruvate levels in the cytosol would
increase HIF-1 activity and the expression of glucose
transporters and glycolytic enzymes, which would
keep sustained glycolytic rates (28,29). Interestingly,
HIF-1 activation can also induce oxphos repression
(13,30). HIF-1 mediates the expression of pyruvate
dehydrogenase kinase; this results in pyruvate
dehydrogenase inhibition, decreased conversion of
pyruvate to acetyl-CoA, reduced activity of the
tricarboxylic acid cycle and subsequent oxphos
repression (13,30).
Additional evidence supports the view that intracellular
alkalinization can activate glycolysis in the presence of
adequate oxygen levels (31-33). Experimental data
have revealed that cancer cells, which are known to
have high rates of aerobic glycolysis, have an increase
in their intracellular pH of 0.13-0.45 units (7.12-7.65
compared with 6.99-7.20 in normal cells) (33,34).
Growth factor-induced proliferation of normal cells has
also been associated with intracellular alkalinization
(mediated by the Na+/H+ antiporter) and with increased
rates of aerobic glycolysis (31,35,36).
An acidic intracellular pH may drive the metabolic
switch from aerobic glycolysis to oxidative
phosphorylation: relevance to cancer
Since a decrease in the cytosolic concentration of H+
(intracellular alkalinization) may drive the metabolic
switch from oxphos to aerobic glycolysis, one can
expect that an increase in the cytosolic levels of H+
(intracellular acidification) can reverse this metabolic
switch (illustration 2). It is well known that the
activation of glycolysis produces H+ in the cytosol. 
Therefore, cells would come back from aerobic
glycolysis to oxphos when the activation of glycolysis
would lead to a concentration of H+ high enough to
reverse the intracellular alkalinization. This increase in
the cytosolic concentration of H+ would raise the
electrochemical H+ gradient across the inner
mitochondrial membrane, which would drive pyruvate
and Pi entry into de matrix and would activate oxphos
(illustration 1). This reduction in the intracellular pH
would also inhibit glycolysis by directly and indirectly
inhibiting PFK activity, and by reducing the expression
of glucose transporters and glycolytic enzymes
induced by pyruvate and mediated by HIF-1
(illustration 2).
Cancer cells are known to have increased glycolytic
rates despite the presence of adequate oxygen levels.
Since an increased glycolytic activity acidifies the
cytosol and an acidic intracellular pH can drive the
metabolic switch from aerobic glycolysis to oxphos,
one could wonder why cancer cells keep increased
glycolytic activity instead of switching back to oxphos.
It has recently been proven that tumor cells do not
necessarily have irreversible damages to oxphos, as
some cancer cells have been forced to switch from
aerobic glycolysis to oxphos (13). Evidence indicates
that tumor cells prevent cytosolic acidification by
activating a number of transporters that extrude the
protons produced during glycolysis (37). This active
proton transport across the cellular membrane can
explain the reversed intra-extracellular pH gradients
found in cancer cells (31,37); experimental data have
demonstrated that tumor cells have alkaline
intracellular pH values (7.12–7.65 compared with
6.99–7.20 in normal tissues) and acidic interstitial
extracellular pH values (6.2–6.9 compared with
7.3–7.4) (33,34). The increased activity of these H+
extruders seems to play a critical role in the
maintenance of high rates of aerobic glycolysis in
cancer cells. The inhibition of these transporters has
already been proposed as an attractive anticancer
strategy that could potentially be used in a wide range
of cancer types (37,38). Inhibition of the sodium pump,
e.g. by cardiac glycosides, may also interfere with
proton extrusion in tumor cells and induce selective
anticancer activity (39,40).
Conclusion
Despite many decades of research, we still do not fully
understand what makes cells choose between
oxidative phosphorylation and glycolysis to produce
energy. It is clear that cells must use glycolysis to
produce energy when oxygen is not available. Here
we have discussed that, in the presence of adequate
oxygen levels, the intracellular pH may play a key role
in determining the way cells obtain energy (illustration
3). This knowledge may be important for the
development of potential cancer preventive and
therapeutic interventions.
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The outer mitochondrial membrane (OMM) contains voltage dependent anion channels (VDAC) that make
this membrane permeable to H+. A decrease in the cytosolic concentration of H+ (intracellular
alkalinization) results in a reduction in the concentration of H+ in the intermembrane space. This decreases
the electrochemical H+ gradient across the inner mitochondrial membrane (IMM) and reduces H+ entry into
the matrix through ATP synthase (as well as pyruvate and Pi transport into the matrix), therefore reducing
ATP synthesis through oxphos. Intracellular alkalinization can also repress oxphos by inducing hexokinase
(HK) binding to VDAC, which can induce VDAC closure and mitochondrial activity repression (see text for
details). ETC: electron transport chain; TCA: tricarboxylic acid cycle.
Illustrations
Illustration 1
Repression of oxidative phosphorylation (oxphos) by intracellular alkalinization. 
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Intracellular alkalinization can activate glycolysis by directly and indirectly increasing the activity of the
enzyme phosphofructokinase (PFK). An alkaline intracellular pH can also keep sustained glycolytic rates
by increasing the expression of glucose transporters and glycolytic enzymes; this effect can be induced by
an increase in the cytosolic concentrations of pyruvate and mediated by the activation of the
hypoxia-inducible factor 1 (HIF-1). Intracellular acidification caused by accumulation of glycolytic
protons in the cytosol can reverse this metabolic switch. Tumor cells keep sustained rates of aerobic
glycolysis instead of coming back to oxphos because they avoid cytosolic acidification e.g. by activating a
number of transporters that pump the protons produced during glycolysis out of the cell (see text for
further details).
Illustration 2
Role of the intracellular pH in the metabolic switch between oxidative phosphorylation and aerobic glycolysis.
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This figure represents in a simplified manner that cells need to activate glycolysis
to generate ATP when the levels of oxygen are reduced or when the levels of oxygen are
adequate but the cytosolic concentration of H+ is reduced (intracellar alkalinization).
Illustration 3
The cytosolic concentration of H  (intracellular pH) may play a key role in determining the way cells obtain energy in the presence of
adequate oxygen levels.
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